[go: up one dir, main page]

AR133217A1 - BICYCLIC AND MONOCYCLIC TRPA1 INHIBITORS - Google Patents

BICYCLIC AND MONOCYCLIC TRPA1 INHIBITORS

Info

Publication number
AR133217A1
AR133217A1 ARP240101791A ARP240101791A AR133217A1 AR 133217 A1 AR133217 A1 AR 133217A1 AR P240101791 A ARP240101791 A AR P240101791A AR P240101791 A ARP240101791 A AR P240101791A AR 133217 A1 AR133217 A1 AR 133217A1
Authority
AR
Argentina
Prior art keywords
bicyclic
monocyclic
trpa1 inhibitors
trpa1
inhibitors
Prior art date
Application number
ARP240101791A
Other languages
Spanish (es)
Inventor
Fabrizio Giordanetto
Morten Stergaard Jensen
Vishwanath Jogini
Roger John Snow
Original Assignee
De Shaw Res Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by De Shaw Res Llc filed Critical De Shaw Res Llc
Publication of AR133217A1 publication Critical patent/AR133217A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Se describe un compuesto de fórmula (1) o (2) o una de sus sales farmacéuticamente aceptables, donde los sustituyentes son como se definen en este documento. Además se describen composiciones farmacéuticas que lo comprenden, y un método para su uso.A compound of formula (1) or (2) or a pharmaceutically acceptable salt thereof is described, wherein the substituents are as defined herein. Pharmaceutical compositions comprising it, and a method for their use, are also described.

ARP240101791A 2023-07-10 2024-07-08 BICYCLIC AND MONOCYCLIC TRPA1 INHIBITORS AR133217A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202363512813P 2023-07-10 2023-07-10

Publications (1)

Publication Number Publication Date
AR133217A1 true AR133217A1 (en) 2025-09-10

Family

ID=94216361

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP240101791A AR133217A1 (en) 2023-07-10 2024-07-08 BICYCLIC AND MONOCYCLIC TRPA1 INHIBITORS

Country Status (3)

Country Link
AR (1) AR133217A1 (en)
TW (1) TW202515569A (en)
WO (1) WO2025014922A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20070405A1 (en) * 2005-08-10 2007-05-06 Smithkline Beecham Corp XANTHINE-DERIVED COMPOUNDS AS AGONISTS OF THE NICOTINIC ACID RECEPTOR HM74A

Also Published As

Publication number Publication date
WO2025014922A1 (en) 2025-01-16
TW202515569A (en) 2025-04-16

Similar Documents

Publication Publication Date Title
ECSP22046699A (en) KRAS G12C INHIBITORS
MX386103B (en) MCL-1 INHIBITORS AND METHODS OF USING THEM.
MX2024010399A (en) 6-oxodecahydropyrrolo[1,2-a][1,5]diazocine and 6-oxodecahydro-4h-pyrrolo[2,1-d][1,5]thiazocine derivatives as stat3 and stat6 modulators for the treatment of cancer and inflammatory conditions
MX2022006608A (en) NEW AURORA KINASE INHIBITORS AND USE THEREOF.
AR122351A1 (en) METHYLQUINAZOLINONE DERIVATIVES AS BRAF INHIBITORS
MX2020007947A (en) ERBB/BTK INHIBITORS.
ECSP10010415A (en) NEW COMPOUNDS THAT ARE ERK INHIBITORS
CL2022003045A1 (en) Heteroaromatic Macrocyclic Ether Chemotherapeutics Related Applications
CO2021000049A2 (en) Ectonucleotidase inhibitors and methods of using them
CR20230578A (en) YEATS ENL/AF9 C-BOUND INHIBITORS
CO2024011857A2 (en) N3-substituted uracil compounds as TRPA1 inhibitors
MX2024009161A (en) PYRROLIDINE COMPOUNDS.
CO2021017202A2 (en) tricyclic compounds
CL2025000672A1 (en) Aminopyrimidine derivatives, CDK2 inhibitors; pharmaceutical composition; use for treating cancer.
MX2022004144A (en) HETEROBYCYCLIC ARYL COMPOUNDS AS BLOCKERS OF THE SHAKER TYPE KV1.3 POTASSIUM CHANNEL.
UY40457A (en) TEAD INHIBITORS AND METHODS OF THEIR USE
CO2024010726A2 (en) Heterocyclic compounds and methods of use
CL2024002379A1 (en) Pharmaceutical composition and comprising diphenyldiazole derivatives methods of use
MX2021004917A (en) CRYSTALLINE SALTS OF A PLASMA KALLIKREIN INHIBITOR.
AR114270A1 (en) 4-METHYLDIHYDROPYRIMIDINONE COMPOUNDS AND THEIR PHARMACEUTICAL USE
AR133217A1 (en) BICYCLIC AND MONOCYCLIC TRPA1 INHIBITORS
EA202190989A1 (en) A NEW METHOD FOR THE SYNTHESIS OF PIPERAZINYL-ETHOXY-BROMPHENYL DERIVATIVES AND THEIR APPLICATION IN THE PREPARATION OF THEIR COMPOUNDS
AR129212A1 (en) PYRIDONE COMPOUNDS AS TRPA1 INHIBITORS
AR131717A1 (en) BICYCLIC IMIDE COMPOUNDS AS TRPA1 INHIBITORS
ECSP23075535A (en) CYCLIC COMPOUNDS AND METHODS OF USE